NR4A1 limits CD8 + T Cell effector responses and protection in tuberculosis

Résumé fourni par la source

Abstract During Mycobacterium tuberculosis ( Mtb ) infection, CD8 + T cells exhibit dysfunction with impaired cytotoxicity and limited localization to granuloma cores. Using knockout mice, adoptive-transfer models and validation in macaque and human datasets, we identified the nuclear receptor NR4A1 as a key restrainer of CD8 + T cell immunity in tuberculosis (TB). Mtb -infected Nr4a1 -/- mice displayed reduced bacterial burden, attenuated pathology, higher lung CD8 + /CD4 + T cell ratios, and enhanced CD8 + T cell effector functions. Bulk and single-cell RNA sequencing revealed suppression of gene expression program linked with exhaustion, and expansion of Nkg7 + and Granzyme + cytotoxic CD8 + T cell subsets in Nr4a1 -/- mice. Spatial analyses demonstrated increased infiltration of Nkg7 + activated CD8 + T cells in Nr4a1 -/- lesions. ChIP-qPCR showed NR4A1 binding to Nkg7 promoter, and Nkg7 knockdown abrogated the enhanced cytotoxicity of Nr4a1 -/- CD8 + T cells. Pharmacologic inhibition of NR4A1 reduced Mtb burden and pathology, and restored Nkg7 expression and CD8 + T cell infiltration in the lung. Together, these findings identify NR4A1 as a negative regulator of CD8 + T cell–mediated immunity in TB and suggest the NR4A1-NKG7 axis as a novel host-directed therapeutic target. A one-sentence summary of your paper NR4A1 suppresses CD8 + T cell infiltration and cytotoxicity in TB lesions, and its inhibition enhances host resistance to Mtb infection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.